Free to follow every thread. No paywall, no dead ends.
Vaccine: the story on HearLore | HearLore
Vaccine
In 1796, a young physician named Edward Jenner performed an experiment that would fundamentally alter the course of human history. He took pus from the blister of a milkmaid who had contracted cowpox, a mild disease affecting cows, and injected it into the arm of an eight-year-old boy named James Phipps. Six weeks later, Jenner exposed the boy to smallpox, the most feared and deadly disease of the era, and the child did not fall ill. This single act of medical daring proved that exposure to a harmless relative of a deadly pathogen could build an impenetrable shield against the killer itself. The term vaccine was derived from the Latin word for cow, vacca, and the phrase variolae vaccinae, meaning smallpox of the cow, which Jenner used to describe his discovery. Before this moment, the only way to prevent smallpox was variolation, a risky practice of deliberately infecting people with actual smallpox scabs, which carried a high mortality rate. Jenner's method was safer, more effective, and could be transferred from arm to arm, eventually allowing for mass distribution. The impact was immediate and profound, leading to the eventual eradication of smallpox, the first and only human disease to be completely wiped from the planet. The legacy of this experiment is not just in the science but in the sheer scale of lives saved, with estimates suggesting that vaccines prevent millions of deaths every year.
The Science Of Memory
The immune system is a complex biological network that learns to recognize threats through a process of memory and adaptation. When a vaccine is introduced, it contains an agent that resembles a disease-causing microorganism, often a weakened or killed form of the microbe, its toxins, or one of its surface proteins. This agent stimulates the immune system to recognize the threat, destroy it, and remember it for future encounters. The body produces antibodies that neutralize the target agent before it can enter cells and destroy infected cells before the agent can multiply to vast numbers. This process, known as adaptive immunity, can take one to two weeks to fully develop, during which time the host remains vulnerable to infection. The effectiveness of this response depends on various factors, including the disease itself, the strain of the vaccine, and the individual's genetic makeup. Some people, known as non-responders, may not generate antibodies even after being vaccinated correctly due to factors such as age, health status, or genetic predisposition. Despite these limitations, vaccines have proven to be the most effective public health tool ever created, preventing untold suffering and saving tens of thousands of lives and billions of dollars in healthcare costs each year. The concept of herd immunity ensures that as long as the vast majority of people are vaccinated, it is much more difficult for an outbreak of disease to occur, let alone spread.
Common questions
When did Edward Jenner perform his first vaccine experiment?
Edward Jenner performed his first vaccine experiment in 1796. He injected pus from a milkmaid's cowpox blister into the arm of an eight-year-old boy named James Phipps to test immunity against smallpox.
What is the origin of the word vaccine?
The term vaccine was derived from the Latin word for cow, vacca. The phrase variolae vaccinae meaning smallpox of the cow was used by Edward Jenner to describe his discovery.
When was smallpox officially declared eradicated?
The World Health Organization declared smallpox eradicated in 1980. This achievement followed widespread vaccination programs and the dedication of health workers around the world.
Which countries currently have endemic polio?
Endemic polio is restricted to only parts of three countries: Afghanistan, Nigeria, and Pakistan. These nations face challenges in reaching all children due to cultural misunderstandings and disinformation.
How long does it take to construct a vaccine production facility?
Vaccine manufacturing plants may take between 4 and 6 years to construct. The full process of vaccine development takes between 10 and 15 years.
When did the World Health Organization identify vaccine hesitancy as a top global health threat?
The World Health Organization characterized vaccine hesitancy as one of the top ten global health threats in 2019. This designation highlights the significant global health threat posed by vaccine hesitancy.
The story of smallpox is a testament to the power of vaccination and the persistence of global health efforts. Before the introduction of vaccination, smallpox was one of the most contagious and deadly diseases in human history, leaving scars on the faces of survivors and killing millions. The first recorded use of inoculation to prevent smallpox occurred in the 16th century in China, with the earliest hints of the practice dating back to the 10th century. The folk practice of inoculation against smallpox was brought from Turkey to Britain in 1721 by Lady Mary Wortley Montagu, who had witnessed variolation in Turkey. In 1796, Edward Jenner's experiment with cowpox provided a safer alternative, leading to the eventual ban of smallpox inoculation in England in 1840. The eradication of smallpox was a monumental achievement, with the World Health Organization declaring it eradicated in 1980. This success was made possible by widespread vaccination programs and the dedication of health workers around the world. The eradication of smallpox has set a precedent for other diseases, such as polio, which is now targeted by an extensive eradication campaign that has seen endemic polio restricted to only parts of three countries: Afghanistan, Nigeria, and Pakistan. The difficulty of reaching all children, cultural misunderstandings, and disinformation have caused the anticipated eradication date to be missed several times, but the goal remains within reach.
The Evolution Of Technology
The development of vaccines has evolved from simple whole-organism vaccines to sophisticated genetic technologies. The first generation of vaccines included live, attenuated microorganisms, such as the smallpox and polio vaccines, which were able to induce killer T-cell responses and antibody immunity. However, attenuated forms of a pathogen can convert to a dangerous form and may cause disease in immunocompromised vaccine recipients. The second generation of vaccines, developed to reduce the risks from live vaccines, included subunit vaccines, consisting of specific protein antigens or recombinant protein components. The third generation of vaccines, which includes RNA and DNA vaccines, represents a new frontier in vaccine development. In 2020, mRNA vaccines such as BNT162b2 were developed with the help of Operation Warp Speed and massively deployed to combat the COVID-19 pandemic. In 2021, Katalin Karikó and Drew Weissman received Columbia University's Horwitz Prize for their pioneering research in mRNA vaccine technology. The evolution of vaccine technology has also seen the development of genetic vaccines, which are based on the principle of uptake of a nucleic acid into cells, whereupon a protein is produced according to the nucleic acid template. This approach offers a number of potential advantages over traditional approaches, including the stimulation of both B- and T-cell responses, improved vaccine stability, the absence of any infectious agent, and the relative ease of large-scale manufacture.
The Economics Of Production
The production of vaccines is a complex and expensive process that requires significant investment and specialized equipment. Depending upon the antigen, it can cost anywhere from US$50 to $500 million to build a vaccine production facility, which requires highly specialized equipment, clean rooms, and containment rooms. There is a global scarcity of personnel with the right combination of skills, expertise, knowledge, competence, and personality to staff vaccine production lines. With the notable exceptions of Brazil, China, and India, many developing countries' educational systems are unable to provide enough qualified candidates, and vaccine makers based in such countries must hire expatriate personnel to keep production going. The companies with the highest market share in vaccine production are Merck, Sanofi, GlaxoSmithKline, Pfizer, and Novartis, with 70% of vaccine sales concentrated in the EU or US. Vaccine manufacturing plants require large capital investments and may take between 4 and 6 years to construct, with the full process of vaccine development taking between 10 and 15 years. The economic challenges of vaccine development are compounded by the fact that many of the diseases most demanding a vaccine, including HIV, malaria, and tuberculosis, exist principally in poor countries. In the United States, financial returns are usually minimal, and the financial and other risks are great. Most vaccine development to date has relied on push funding by government, universities, and non-profit organizations. The World Trade Organization and governments around the world have evaluated whether to waive intellectual property rights and patents on COVID-19 vaccines, which would eliminate all potential barriers to the timely access of affordable COVID-19 medical products, including vaccines and medicines, and scale up the manufacturing and supply of essential medical products.
The Challenge Of Hesitancy
Despite the overwhelming scientific consensus that vaccines are generally safe and effective, vaccine hesitancy remains a significant global health threat. The term covers outright refusals to vaccinate, delaying vaccines, accepting vaccines but remaining uncertain about their use, or using certain vaccines but not others. Vaccine hesitancy often results in disease outbreaks and deaths from vaccine-preventable diseases. The World Health Organization characterized vaccine hesitancy as one of the top ten global health threats in 2019. The phenomenon is driven by a complex interplay of factors, including complacency, lack of confidence, and convenience. In the United States, a partisan gap in death rates developed after the December 2020 introduction of COVID vaccines, with more than 30 percent of Republicans having not received a COVID-19 vaccine, compared with less than 10 percent of Democrats. The history of vaccine hesitancy dates back to the early days of vaccination, with early 19th-century satires of antivaxxers by Isaac Cruikshank highlighting the public's fear and skepticism. The challenge of vaccine hesitancy is compounded by the fact that vaccines are often taken for granted, and the public may not fully appreciate the risks of vaccine-preventable diseases. The World Health Organization and governments around the world are working to address vaccine hesitancy through education, communication, and policy interventions. The goal is to build trust and acceptance of licensed vaccines among the public to ensure that vaccination campaigns proceed smoothly, save lives, and enable economic recovery.